Viewing Study NCT06254495


Ignite Creation Date: 2025-12-24 @ 1:29 PM
Ignite Modification Date: 2025-12-29 @ 7:46 AM
Study NCT ID: NCT06254495
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-09
First Post: 2024-02-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hodgkin Disease View
None Lymphoma, T-Cell, Peripheral View
None Lymphoma, Large B-Cell, Diffuse View
None Lymphoma, Large-Cell, Anaplastic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cHL View
None PTCL View
None sALCL View
None DLBCL View
None Seattle Genetics View
None ADC View
None Anti Drug Conjugate View